Sudden Cardiac ArrestHeart and circulationDevice
What this study is
A Prospective study on the performance and safety of the HeartStart OnSite (Model M5066A) \& HeartStart Home (Model M5068A) Defibrillator device data.
What's being tested
- HeartStart HS1
Intervention · DEVICE
Automated External Defibrillator
Study details
- Sponsor
- Philips Clinical & Medical Affairs Global
- Conditions
- Sudden Cardiac Arrest
- Enrolling
- 1,400 people
- Starts
- 2021-02-25
- Est. completion
- 2027-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Have been suspected of a circulatory arrest for any cause.
- Have had HeartStart HS1 Defibrillator with electrodes: Adult SMART Pads Cartridge [REF: M5071A], Infant/Child SMART Pads Cartridge (REF:M5072A) applied to their body and powered up with HS1 battery (Model M5070A), regardless of whether a defibrillation shock was delivered
You can't join if
- AED or pad use other than the HeartStart HS1 Defibrillator with above referenced Philips electrode pads. Note: Use of a device other than the Philips HeartStart HS1 AED does not preclude enrollment if the AED or an Advanced Life Support defibrillator was used after the HeartStart HS1 AED.
- AED used for training purposes.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openPhilips
Pittsburgh, Pennsylvania, United States
- Chase Wennick · Contact617-398-7347chase.wennick@philips.com
- Gerrit Nordergraaf, MD PhD · Principal investigator
Recruiting
Study team
Sponsor
Philips Clinical & Medical Affairs Global
Study ID TC_ECR_HS1_2020_10819
Principal investigator
Gerrit Noordergraaf, MD PhD
Philips Healthcare
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.